Numeric Investors’s Supernus Pharmaceuticals SUPN Stock Holding History

Numeric Investors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.98M	Sell	49,765 -2,135	-4%	-$84.4K	0.01%	642
2017 Q3	$2.08M	Buy	51,900 +35,600	+218%	+$1.54M	0.02%	589
2017 Q2	$703K	Buy	16,300 +4,900	+43%	+$174K	0.01%	746
2017 Q1	$357K	Sell	11,400 -13,300	-54%	-$356K	﹤0.01%	864
2016 Q4	$624K	Buy	24,700 +6,000	+32%	+$134K	0.01%	768
2016 Q3	$462K	Buy	+18,700	New	+$423K	﹤0.01%	804
2016 Q2	–	Sell	-13,900	Closed	-$212K	–	1161
2016 Q1	$212K	Sell	13,900 -64,600	-82%	-$843K	﹤0.01%	918
2015 Q4	$1.05M	Buy	78,500 +39,600	+102%	+$613K	0.01%	575
2015 Q3	$546K	Buy	+38,900	New	+$723K	0.01%	682

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Numeric Investors's SUPN Position: Q4 2017 in Review

Numeric Investors reduced its Supernus Pharmaceuticals (SUPN) stake by 4.1% in Q4 2017, selling an estimated $84.4K and leaving 49,765 shares worth $1.98M. The position accounts for 0.01% of the portfolio, ranked #642.

Numeric Investors first reported a position in SUPN in Q3 2015 and has held it in 9 quarters since. The position peaked at $2.08M in Q3 2017. 297 funds tracked by Wall St. Rank hold SUPN as of Q4 2017.

Numeric Investors held 49,765 shares of Supernus Pharmaceuticals worth $1.98M as of Q4 2017.
Numeric Investors sold 2,135 Supernus Pharmaceuticals shares in Q4 2017, an estimated $84.4K.
Supernus Pharmaceuticals made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #642 holding.
Numeric Investors first reported a position in Supernus Pharmaceuticals in Q3 2015 and has held it in 9 quarters since.
Numeric Investors's Supernus Pharmaceuticals position peaked at $2.08M in Q3 2017.
297 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.